FDA Approved Drugs: Changes to Approved Drugs
10:03Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:29The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
14:01Isolation and Derivation of Mouse Embryonic Germinal Cells
Obedience
Ethics in Research
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jan 20, 2026
FDA Approved Drugs: Changes to Approved Drugs
Published on: October 3, 2025
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand. dru@adis.com.
格丁尼布是一种新的HER2特异性抑制剂,已批准用于治疗HER2突变非小细胞肺癌 (NSCLC). 这一里程碑是在Beamion LUNG-1试验的积极结果之后实现的,为高级NSCLC患者提供了新的治疗选择.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: